Approved comparison material connected to this topic.
7 total recordsSource comparisons are presented without a generated winner.
Sermorelin (1-29) Yes Pulsatile GH studies CJC-1295 Extended Long-duration GH studies Tesamorelin (1-40) Moderate Metabolic/GH axis research Native GHRH (1-44) Very short Baseline comparisons Table 2: Mechanis…
Sermorelin (1-29 NH2) ~2-3 min (rat) None Modified GRF 1-29 (CJC-1295 no DAC) ~30 min Amino acid substitutions CJC-1295 with DAC ~6-8 days Albumin binding via DAC Tesamorelin (1-40) ~30-40 min Extended C-termi…
Intravenous (IV) 100% Immediate PK studies, acute GH response studies Subcutaneous (SC) ~40-70% 5-10 minutes Standard animal model studies Intranasal Low Variable Delivery route comparative studies Oral Neglig…
Sermorelin GHRH(1-29) ~20-30 min Pulsatile, physiological Aging GH axis; receptor sensitivity studies Link CJC-1295 (no DAC) GHRH(1-29) modified ~30 min to 2 hr Pulsatile, extended DPP-IV resistant studies; mo…
Choosing between Sermorelin, CJC-1295 without DAC, and CJC-1295 with DAC comes down to what question the research design is asking: Use Sermorelin when: Research requires pulsatile GH stimulation that closely …
Amino acid length 29 44 N-terminus Tyrosine (Tyr, Y) C-terminus Arginine-NH2 Leucine-NH2 GHRHR agonist activity Full agonist Plasma stability Low (rapid degradation) Molecular weight ~3,357 Da ~5,040 Da Table …
29 aa 29 aa (modified) 40 aa Amide Key modification None DAC / amino acid subs Extended C-tail Met oxidation risk Present (Met27) Reduced Present Water solubility High GHRHR selectivity Table 3: Structural com…